The Safety and Efficacy of DCA for the Treatment of Brain Cancer

NCT00540176 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Malignant Gliomas, Glioblastoma Multiforme

Interventions

DRUG: Dichloroacetate (DCA)

Sponsor

University of Alberta

Collaborators

[object Object]